Replay available

Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2025 Earnings Call

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.

Thu, August 7, 2025 at 4:30 PMendedReplay
Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2025 Earnings Call

Hosted by

Featured presenters

Gayathri De Walker

Head of Investor Relations

Dr. Scott Struthers

Founder and Chief Executive Officer

Isabel Calazono

Chief Commercial Officer

Dr. Dana Pizzuti

Chief Medical and Development Officer

Toby Schoke

Chief Financial Officer

Dr. Steve Betts

Founder and Chief Scientific Officer

Dr. Alan Krasner

Chief Endocrinologist

Joe Schwartz

Analyst, Leerink Partners

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Crinetics Pharmaceuticals, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.218 Welcome to Krenetics Pharmaceutical School's second quarter 2025 financial results conference 00:00:05.218 -- 00:00:08.724 call. At this time, all participants are on listen-only mode. 00:00:08.724 -- 00:00:12.229 Following the management's prepared remarks, we will hold a question and answer session. 00:00:12.229 -- 00:00:15.553 In order to raise a question, please signal by pressing star followed by one on your 00:00:15.553 -- 00:00:19.078 telephone keypad. To remove yourself from the line of questioning, it will be star followed 00:00:19.078 -- 00:00:24.967 by two. And I would like to turn the call over to Gayathri De Walker, 00:00:24.967 -- 00:00:27.571 Head of Investor Relations. Please go ahead. 00:00:27.571 -- 00:00:31.562 Thank you, Operator. Good afternoon, everyone, and thank you for joining us to discuss 00:00:31.562 -- 00:00:35.869 the second quarter 2025 results. Today on the call, we have Dr. 00:00:35.869 -- 00:00:39.434 Scott Struthers, Founder and Chief Executive Officer, Dr. 00:00:39.434 -- 00:00:44.783 Dana Pizzuti, Chief Medical and Development Officer, Isabel Calazono, Chief Commercial 00:00:44.783 -- 00:00:48.428 Officer, and Toby Schoke, Chief Financial Officer. 00:00:48.428 -- 00:00:52.795 In addition, Dr. Steve Betts, Founder and Chief Scientific Officer, and Dr. 00:00:52.795 -- 00:00:57.912 Alan Krasner, Chief Endocrinologist, will also be joining for the Q&A portion. 00:00:57.912 -- 00:01:01.997 Please note there's a slide deck for today's presentation, which is in the Events and 00:01:01.997 -- 00:01:06.102 Presentations section of the Investors page on the Kinetics website. 00:01:06.102 -- 00:01:10.728 In addition, a press release was issued earlier today and is also available on the corporate 00:01:10.7...